ConV2X Announces Cross Sector Executive Speaker Roster for NYC Executive Health Tech Summit

Partners in Digital Health has announced the confirmed speaker lineup for ConV2X 2026: Smart Technology Transformation in Healthcare, taking place October 29–30, 2026, at the ILR Conference Center, 570 Lexington Avenue in New York City. The two day executive summit will convene leaders responsible for implementing artificial intelligence, virtual care, data intelligence, connected health technologies and new healthcare delivery models.

ConV2X is designed for executives seeking more than predictions about the future of healthcare. Its program will examine what is being deployed now, what is producing measurable value, what is failing to scale and what leadership, governance, evidence and infrastructure are required to move innovation into enterprise adoption.

Featured Keynote
Dr. Ashish Jha, Senior Fellow at the Harvard Kennedy School’s Belfer Center, Co-Founder and CEO of BioRadar, and former White House COVID-19 Response Coordinator, will deliver the keynote: “Misdiagnosed: The Real Drivers of Healthcare Costs and How to Fix Them.” The keynote will examine the structural forces driving healthcare spending and the changes required to improve affordability, outcomes and system performance.

Government, Policy and Public Health Leadership
Public sector, policy and institutional leaders will address AI governance, healthcare economics, public health resilience and the policy conditions required to support responsible innovation.

• Andrew Philip, PhD, Deputy Director, Learning and Diffusion Group, Center for Medicare and Medicaid Innovation
• José A. Pagán, PhD, Professor and Chair, Department of Public Health Policy and Management, School of Global Public Health, New York University, and Chair, Board of Directors, NYC Health + Hospitals
• Rebekah Hayoung Woo, United Nations Office for Digital and Emerging Technologies
• Syra Madad, DHSc, MSc, MCP, CHEP, Assistant Vice President, Office of Biopreparedness and Emergency Management, and Chief Biopreparedness Officer, NYC Health + Hospitals
• Eric Wei, MD, CEO, NYC Health + Hospitals/Bellevue
• Michael Dulin, MD, AI Training Faculty, National Academy of Medicine’s Robert Wood Johnson Health Policy Fellows Program

Health Systems, Clinical Leadership and Virtual Care
Healthcare executives, physicians and transformation leaders will examine enterprise AI adoption, virtual care, connected health, clinical workflow integration and the evidence required to move successful programs beyond the pilot stage, including workforce performance, patient access, quality, cost and the design of care delivery across institutional and virtual environments.

• Innocent Clement, MD, Founder and CEO, Ciba Health
• Tania Elliot, MD, Founder and CEO, Modern Med
• Michael Carter, Senior Director, Enterprise IT Architect, Mass General Brigham
• Drew Schiller, CEO, Validic
• Saurabh Chandra, PhD, Chief Telehealth Officer, Center for Telehealth and Emerging Technologies, University of Mississippi Medical Center
• Jerrold M. Jackson, PhD, Director, Partner Enablement, Mayo Clinic Platform
• Steve Arbogast, DO, Medical Director of Product and Innovation, Sevaro
• Rajiv Narula, MD, CEO, Sevaro
• Dr. Suhail Chughtai, Orthopaedic Surgeon, Co-Editor in Chief, Telehealth and Medicine Today, and AI Division Head, UKDHC
• Iris Berman, Principal of Quality and Performance Improvement for Virtual Care, Northwell Health
• Daniel Jafari, MD, Associate Professor, Northwell Health
• Erkan Hassan, Managing Partner, Virtual Care, ProNexus Advisory
• John Campbell, Principal, Campbell Healthcare Digital Associates LLC
• Leon Wisniewski, Founder, Health Cost Lab

Life Sciences, Pharmaceutical Strategy and Clinical Development
Life sciences executives will examine how AI, digital systems and data products are changing clinical development, medical affairs, patient engagement and pharmaceutical strategy, The life sciences program will address AI enabled research, clinical development, evidence generation, data strategy, patient centered innovation and collaboration across pharmaceutical, clinical and technology organizations.

• Bob Spurr, Executive Vice President, North America, LEO Pharma
• Lestter Cruz Serrano, MD, BCMAS, former Head of Global Medical Affairs for Life Sciences and Healthcare, Cognizant
• Christine Korbmacher, Senior Director, Clinical Development, Axsome Therapeutics
• Julia Brodsky, Vice President of Data Products and AI, Johnson & Johnson
• Nikki Romanik, President, BioRadar
• CK Singla, Co-Founder and Co-CEO, Pharma Acuity
• Klara Czobor, Co-Founder and Co-CEO, Pharma Acuity

AI, Data Intelligence and Enterprise Technology
Researchers, AI leaders and technology executives will address the architecture, governance and integration of intelligent systems across healthcare and life sciences, focusing on applied AI, enterprise architecture, interoperability, data quality, explainability, implementation readiness and the operational requirements for trustworthy deployment.

• Deepak Mittal, CEO, NextGen Invent Corporation
• Dr. Eugene Kolker, Co-Founder and Chief AI
• Murari Srinivasan, CEO, Codex Health, Inc.
  
  
• Maulik Bhansali, CEO, NetWebBiz
• Elizabeth Baker, PhD, Professor of Information Systems, Virginia Commonwealth University
• Dirk Schroder, CEO, Updraft Health Innovation Advisors

Value Based Care, Business Strategy and Market Transformation
Healthcare business and strategy leaders will examine how organizations can align emerging technologies with sustainable care models, measurable outcomes and enterprise value, addressing commercialization, value based care, enterprise procurement, market readiness, operational performance and the business case for scaling new technologies.

• Erik Johnson, Senior Vice President and National Practice Lead, Value Based Care, Optum
• Alex Romanovich, CEO, GlobalEdgeMarkets
• Andrea Ippolito, CEO, Simplifed
• Mark Amouzgar, CEO, March Health
• Marissa Fayer, CEO, DeepLook Medical

Legal, Regulatory and Strategic Risk
Legal and regulatory leaders will examine the contractual, compliance, data governance and risk considerations accompanying healthcare AI and digital transformation, addressing how companies can develop responsible innovation strategies while navigating evolving regulatory, privacy, contracting and enterprise risk requirements.

• Charles Dunham, Shareholder, Greenberg Traurig
• Carrie Nixon, Managing Partner, Nixon Law Group

Venture2X: Connecting Innovation with Capital and Enterprise Adoption
ConV2X 2026 new Venture2X, is a dedicated track connecting healthcare startups and emerging companies with investors, strategic partners, health system leaders and enterprise decision makers. Venture2X will focus on questions that determine whether healthcare technologies move from promising concepts to scalable companies:

• Does the solution address a clearly defined healthcare problem?
  
  
• Is there credible clinical, operational or financial evidence?
  
  
• Can the technology integrate with existing healthcare infrastructure?
  
  
• Is the company prepared for regulatory and enterprise requirements?
  
  
• What will investors, health systems and strategic partners require before committing capital or entering a commercial relationship?
  
  

Registered companies will have opportunities to present solutions, receive market feedback and build relationships with healthcare leaders, investors and potential partners.

A High Signal Executive Environment
ConV2X attendance is capped to preserve candid discussion, senior level access, and meaningful relationship building. The summit is vendor neutral and structured around substantive content – operating under Chatham House Rule.

The 2025 NYC summit received exceptional participant feedback:

• 100% overall attendee satisfaction
• 100% would recommend ConV2X to colleagues
• 100% rated speaker quality Excellent
• 100% rated keynote presentations Excellent
• 96% rated networking opportunities Excellent
• 96% rated conference content quality Excellent
• 96% rated session relevance Excellent
• 96% were Very Likely to attend a future ConV2X event
• 89% said the insights gained were Very Likely to influence their organizations

Attendees describe ConV2X as “a can’t miss event,” citing the high quality speakers, limited attendance and caliber of participants.

Registration
Early Bird Registration is open at:
https://telehealth.conv2xsymposium.com/shop/?add-to-cart=3259

ConV2X 2026: Smart Technology Transformation in Healthcare October 29–30, 2026: ILR Conference Center: 570 Lexington Avenue: New York, New York Attendance is limited to preserve executive dialogue, direct access, and high value networking environment.

MORE SPEAKERS TO BE ADDED.

Sponsorship and Strategic Partnerships

• Ramy Azzam, Head of Partnerships & Strategy, Partners in Digital Health
  r.azzam@partnersindigitalhealth.com
• Alex Romanovich, ConV2X Media Partner and CEO, GlobalEdgeMarkets
  alexr@globaledgemarkets.com  ­

About Partners in Digital Health
Partners in Digital Health (PDH) is a healthcare communications, publishing and convening organization advancing evidence based innovation across digital health, artificial intelligence, telehealth and decentralized health systems. The portfolio includes the peer reviewed journals Telehealth and Medicine Today and Blockchain in Healthcare Today: Platform Approaches, the ConV2X symposium series, podcasts, executive programs and the Coalition for Decentralized Healthcare and Life Sciences.PDH connects the architects, researchers, policymakers and executive leaders shaping the next generation of healthcare infrastructure and delivery.

Contact Information

Tory Cenaj

Founder and Publisher

Partners in Digital Health

(1) 2032433063

t.cenaj@partnersindigitalhealth.com